Immunohistochemistry (IHC) is a powerful diagnostic technique that uses antigen-antibody reactions to detect specific proteins in tissue sections. At ROS CURE DIAGNOSTICS LLP, IHC is an integral part of cancer diagnostics, helping to identify tumor type, origin, and biological behavior with high precision.
IHC is especially valuable in cases where standard microscopic examination is inconclusive. It plays a critical role in tumor classification, grading, and prognosis, enabling oncologists to plan targeted therapies. For example, IHC markers are essential in diagnosing breast cancer, lymphomas, neuroendocrine tumors, and metastatic cancers of unknown origin.
Using an extensive panel of antibodies, our laboratory identifies cellular markers such as ER, PR, HER2, Ki-67, CD markers, cytokeratins, and many more, depending on clinical needs.
Each test is meticulously validated and interpreted by experienced professionals, ensuring clinical relevance and diagnostic confidence.
Key Features:
At ROS CURE DIAGNOSTICS LLP, IHC adds a critical layer of precision to pathology, transforming tissue samples into valuable clinical answers for better patient outcomes.
